Central Hospital - University Hospital
Nancy, 54000, France
NCT Number: NCT02910856
ELDERL-IE is a multicenter national prospective observational study.
The main objective is to describe geriatric characteristics (comorbidities, cognitive status, autonomy, nutritional status, balance and walking) in patients aged 75 years or older with infective endocarditis (IE).
The secondary objectives are to assess the impact of geriatric features on the medico - surgical care and on morbidity and mortality at 3 months after the end of the hospitalization, and to describe the initial clinical presentation and diagnostic modalities in the IE elderly.
Looking for future studies?
Notify Me75 year and older
All sexes
Observational
Nancy, 54000, France
Population monitoring:
Clinical, therapeutic, biological, microbiological, echocardiographic and geriatric data are collected. (M-2/3 before inclusion; D-15 before inclusion; D0; M3; vital status at 1 year)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months after inclusion
OMS score
Time frame: 3 months after inclusion
Mortality rate at 3 months
Time frame: 1 year after inclusion
Mortality rate at 1 year
Time frame: 3 months after inclusion
Karnofsky'score
Time frame: 3 months after inclusion
Score MNA
Central Hospital, Nancy, France
Other
Infective Endocarditis in the Elderly: Description of the Geriatric Characteristics and Their Influence on Therapeutic Care and the Morbidity and Mortality at 3 Months (ELDERL-IE)
Acronym: ELDERL-IE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03683355
Cardiovascular Diseases, Endocarditis
Québec, Quebec, Canada
View Trial DetailsNCT02701608
Cardiovascular Diseases, Endocarditis
Amiens, France
View Trial DetailsNCT02701595
Cardiovascular Diseases, Endocarditis
Amiens, France
View Trial DetailsNCT02287792
Cardiovascular Diseases, Disease
Paris, France
View Trial Details